EKSO BIONICS HOLDINGS, INC. financials

CHRN CIK 0001549084

Source: EDGAR filings · Built 2026-06-19T00:39:59Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -11.99M -9.88M -12.21M -14.88M -11.21M -8.76M
EBITDA -11.75M -8.85M -13.41M -14.67M -12.80M -12.67M
Working Capital 5.41M 11.31M 12.09M 21.84M 40.94M 13.45M
Net Debt 3.48M 1.49M -1.47M -13.02M -38.18M -9.01M
Gross Margin 53.48% 53.06% 49.67% 48.13% 60.01% 57.08%
Operating Margin -104.12% -58.35% -82.67% -120.48% -122.96% -149.64%
Net Margin -91.37% -63.21% -83.14% -116.79% -86.82% -178.17%
Return on Equity (ROE) -129.56% -89.16% -120.56% -59.27% -26.23% -356.90%
Return on Assets (ROA) -58.15% -42.51% -52.56% -36.87% -19.86% -76.83%
Current Ratio 1.63× 2.50× 2.49× 3.37× 6.97× 3.70×
Debt-to-Equity 0.51× 0.47× 0.57× 0.29× 0.06× 0.87×
Effective Tax Rate 0.00%
Cash Conversion Ratio 1.01× 0.87× 0.79× 0.97× 1.14× 0.55×
Accruals Ratio 0.01× -0.06× -0.11× -0.01× 0.03× -0.34×
SBC % of Revenue 11.52% 7.66% 10.16% 19.72% 20.71% 27.13%
CapEx Coverage -62.77× -266.11× -76.78× -75.71× -189.08×
Free Cash Flow Per Share $-5.03 $-0.49 $-0.88 $-1.15 $-0.91 $-1.22

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cost of Goods and Services Sold 5.95M 8.41M 9.20M 6.70M 4.50M 3.81M
Gross Profit 6.84M 9.51M 9.08M 6.21M 6.75M 5.07M
Research and Development Expense 3.03M 3.87M 5.03M 3.63M 2.55M 2.47M
Operating Expenses 20.17M 19.97M 24.19M 21.77M 20.58M 18.36M
Operating Income (Loss) -13.33M -10.46M -15.11M -15.56M -13.83M -13.29M
Income Tax Expense (Benefit) 0
Net Income (Loss) Attributable to Parent -11.70M -11.33M -15.20M -15.08M -9.76M -15.82M
Earnings Per Share, Basic $-4.91 $-8.43 $-1.10 $-1.16 $-0.80 $-2.21
Weighted Average Number of Shares Outstanding, Basic 2.43M 1.34M 13.87M 12.96M 12.19M 7.16M
Earnings Per Share, Diluted $-4.91 $-8.43 $-1.10 $-1.16 $-0.88 $-2.21
Weighted Average Number of Shares Outstanding, Diluted 20.16M 13.87M 12.96M 12.27M 7.16M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.17M 4.49M 8.64M 20.52M 40.41M 12.86M
Assets, Current 14.05M 18.84M 20.21M 31.04M 47.80M 18.42M
Assets 20.11M 26.65M 28.92M 40.90M 49.17M 20.60M
Long-term Debt 1.99M 1.99M
Liabilities, Current 8.64M 7.54M 8.12M 9.20M 6.86M 4.97M
Long-term Debt, Excluding Current Maturities 1.99M 1.99M
Liabilities 11.08M 13.95M 16.31M 15.46M 11.95M 16.16M
Stockholders' Equity Attributable to Parent 9.03M 12.71M 12.61M 25.44M 37.22M 4.43M
Common Stock, Shares, Outstanding 3.56M 1.48M 14.85M 13.20M 12.69M 8.35M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -11.80M -9.85M -12.05M -14.69M -11.16M -8.76M
Payments to Acquire Property, Plant, and Equipment 188.00K 37.00K 157.00K 194.00K 59.00K 0
Net Cash Provided by (Used in) Investing Activities -188.00K -37.00K -157.00K -5.17M -59.00K 0
Net Cash Provided by (Used in) Financing Activities 6.63M 7.77M 348.00K 0 38.71M 10.70M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CHRN CIK 0001549084), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

VTGN

Vistagen Therapeutics, Inc.

EBGEF

ENBRIDGE INC.

NEWP

New Pacific Metals Corp.